Quillivant XR 750 mg/150mL

Quillivant XR 750 mg/150mL is an extended-release oral suspension containing methylphenidate hydrochloride. It is commonly used for attention deficit hyperactivity disorder (ADHD) management. This medication helps improve focus and reduce impulsivity.

Quillivant XR is primarily used for the treatment of ADHD in patients who require extended-release medication. It works by affecting certain chemicals in the brain that may be unbalanced in individuals with ADHD. This suspension form is designed to provide a steady release of the active ingredient throughout the day, helping to manage symptoms effectively.

Common effects of Quillivant XR may include decreased appetite, trouble sleeping, and mild stomach upset. Some users may also experience dry mouth or headaches. These effects vary among individuals and are not experienced by everyone who takes the medication.

Quillivant XR should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be shared with others, even if they have similar symptoms.

Quillivant XR may interact with certain medications, including MAO inhibitors, antidepressants, and some blood pressure medications. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication.